Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Close this search box.

Commercial Biomanufacturing

Syngene offers cGMP manufacturing services for both microbial and mammalian cell-based processes. We specialize in the production of therapeutic biologics such as recombinant proteins and monoclonal antibodies for pre-clinical, clinical and commercial supply.
We have catered to multiple clients globally for their manufacturing requirements of material for pre-clinical and late phase clinical as well as commercial manufacturing. Multiple fermentation processes that include batch, fed-batch, and perfusion technologies are available. The team is experienced in transferring-in processes with minimal engineering and scale-up runs. Our facilities are independent state-of-the-art cGMP production units with combination of single use and reusable process equipment, for microbial fermentation and mammalian cell culture derived products.
Our capabilities include Clinical and Commercial scale production. We have extensive experience in novels and Bio-similar mAbs. We have well-established Quality Management System and Document Management System with Electronic Records and Electronic Signature (ERES)compliant equipment. Our facility is equipped to handle remote audits.
Our Biologic Manufacturing facility can cater to multiproduct production campaigns simultaneously based on single use technology platform. It is designed for supporting our clients for long term commercial manufacturing campaigns. We have a wide range of sophisticated and high-end equipment and rich experience on handling cell culture-based products.

Upstream Process Suites

Scale Details Of Dedicated Manufacturing Facility

Upstream: Two suites (from Inoculum to Production reactors), 3 x 2KL

Downstream Process Suites

Scale Details Of Dedicated Manufacturing Facility


Continuous centrifuge (up to 2000 LPH flow rate) and/or Depth Filtration (up to 44 sqm area)


  • Pre-viral (two rooms – with all chromatography steps, UFDF, Viral filtration)
  • Post viral (one room –UFDF and final filtration – closed operation),
  • Can handle products with 4 chromatography steps – Flow rate up to 2000LPH
  • Column size > 800mm (depends process and operating conditions), currently till 600mm

Biologics (Microbial) Manufacturing Plant

cGMP Microbial (facility to be operational by Q4 2020 )

Major Equipments

  • 200L (SS) and 500L (SS) fermenters
  • Continuous centrifuge
  • Cell homogenizer
  • Chromatogaphy systems
  • TFF systems


  • Recombinant proteins from bacteria and yeast with intracellular or secreted expression
  • Live biotherapeutic products (LBP)


  • Up to 500L (SS) fermentation, 1000L refolding, 60-cm column chromatography and 10-sq.m. tangential flow filtration

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements. To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details